Canopy Growth Corp’s (TSX:WEED) Stock Remains the Pot Industry’s Top Pick

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) popped 31% after releasing earnings. Yet the big news was the $5 billion investment by Constellation Brands Inc. (NYSE:STZ).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It turns out I was only half right. Earlier this week, I’d said that the fate of the pot industry lies with Canopy Growth (TSX:WEED)(NYSE:CGC). Yesterday, Canopy posted first-quarter results, and the stock exploded for a 31% gain.

As anticipated, the entire pot industry rose in unison. Its closest competitors, Aurora Cannabis and Aphria each rose 20% on subsequent optimism. This is yet another example why Canopy Growth is the most influential company in the industry.

Yet there is a caveat. I was only half right because it wasn’t Canopy’s earnings that drove the huge gains. The real catalyst was the announcement that Constellation Brands (NYSE:STZ) took an additional $5 billion stake in the company at $48.60 a share. I won’t go into too many details on the deal, as Fool contributor David Jagielski does a good job of breaking it down.

The deal does two things: it further legitimizes the industry by injecting much-needed confidence, and it creates a false sense of a floor price under the shares.

Let me explain.

Warrant pricing

As part of the transaction, Constellation Brands also received 139.7 million in new warrants. If exercised in full, Constellation will increase its ownership to 50% of the company.

A warrant gives the holder the right to buy the company at a specific price within a set time frame. In this case, the time frame is three years. Likewise, 66% of the warrants can be exercised at a price of $50.40 per share. What remains can be exercised at Canopy’s five-day volume weighted average price (VWAP) of the common shares on the Toronto Stock Exchange.

This VWAP is unknown. It can be $20 or $100; it all depends if or when Constellation Brands chooses to exercise these warrants. This is why the deal doesn’t set a floor price. Canopy’s stock price can tank, and Constellation can pick up additional shares on the cheap and let the remaining warrants with a price of $50.40 expire.

There is no doubt that the significant investment and premium paid by Constellation is great news for the sector. It is, after all, the largest ever investment in the industry. Just don’t be tricked into thinking there is now a floor price under Canopy’s shares.

Cost per gram

Fool contributor Brian Paradza gave a favourable review of Canopy’s latest earnings. One of the biggest gripes about the company is that it does not provide a cost-per-gram number, but this is the industry standard.

Canopy touts that its price per gram rose to $8.94 for the quarter. This is a 6% increase over the previous quarter. That’s great, but it doesn’t actually mean anything unless you have a cost to compare it to.

The company claims there are too many inconsistencies across the industry to make the cost per gram meaningful. It believes a cost structure is better suited if it was broken down by milligram and active ingredient. Fair enough. I would argue, however, that by posting its price-per-gram number, it is using a double standard.

At this stage, I would not read too much into the lack of a costing metric. The company is rapidly scaling, and it is undergoing significant costs, as it tries to ramp up production to meet demand come October.

I would also not put any stock in the company’s net income. As we saw this quarter, income is being significantly impacted by one-time expenses.

Bottom line, the sector will remain volatile. However, if you don’t want to miss out, Canopy remains the safest investment in the industry.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Mat Litalien is long Aurora Cannabis Inc.   

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

senior relaxes in hammock with e-book
Dividend Stocks

How I’d Invest $8,200 in Canadian Monthly Dividend Stocks to Pay for My Retirement Lifestyle

If you have some cash on hand, then these monthly dividend stocks can provide you with cash for life.

Read more »

protect, safe, trust
Investing

Protecting a $5,000 Investment: Why I’m Considering These 3 Defensive Stocks

These three top Canadian value stocks look well-positioned to provide portfolio stability and long-term upside for those navigating market turmoil.

Read more »

Canada national flag waving in wind on clear day
Investing

Where I’d Find Value in Canadian Stocks for My Long-Term Holdings

For investors seeking meaningful value (and long-term upside) from top Canadian stocks, here are two great examples to dive into…

Read more »

Circuit board with glowing lines
Tech Stocks

Got $1,500? How I’d Allocate it Between 2 Tech Stocks for Decades of Potential Growth

Are you looking to put $1,500 to work? These two Canadian tech stocks are a great place to start.

Read more »

man is enthralled with a movie in a theater
Investing

Is Now a Good Time to Buy Cineplex?

The decision of whether it's a good time to buy Cineplex has confounded investors since the pandemic, but It may…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Investing

Why I’d Consider These 3 TSX Stocks Under $100 for my $7,000 TFSA Contribution

Here are three top TSX stocks I think long-term investors would do well to own in their TFSAs during this…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

Here’s Exactly How $20,000 in a TFSA Could Grow to $300,000

Can you grow $20,000 into $300,000 by holding the iShares S&P/TSX Index Fund (TSX:XIC) in a TFSA?

Read more »

Blocks conceptualizing the Registered Retirement Savings Plan
Retirement

Top Canadian Value Stocks I’d Buy for My RRSP and Hold Through Retirement

If you're looking for strength in your RRSP, then look for value in long-term holds.

Read more »